These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9329455)

  • 21. Early destruction of the extracellular matrix around parvalbumin-immunoreactive interneurons in Creutzfeldt-Jakob disease.
    Belichenko PV; Miklossy J; Belser B; Budka H; Celio MR
    Neurobiol Dis; 1999 Aug; 6(4):269-79. PubMed ID: 10448054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parahippocampal pathology in Creutzfeldt-Jakob disease.
    Kaneko M; Arai K; Hattori T; Imai T
    Clin Neuropathol; 1999; 18(1):9-16. PubMed ID: 9988133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parvalbumin, calbindin, and calretinin mark distinct pathways during development of monkey dorsal lateral geniculate nucleus.
    Yan YH; Winarto A; Mansjoer I; Hendrickson A
    J Neurobiol; 1996 Oct; 31(2):189-209. PubMed ID: 8885200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia.
    Freund TF; Buzsáki G; Leon A; Baimbridge KG; Somogyi P
    Exp Brain Res; 1990; 83(1):55-66. PubMed ID: 2073950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution, morphological features, and synaptic connections of parvalbumin- and calbindin D28k-immunoreactive neurons in the human hippocampal formation.
    Seress L; Gulyás AI; Ferrer I; Tunon T; Soriano E; Freund TF
    J Comp Neurol; 1993 Nov; 337(2):208-30. PubMed ID: 8276998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of the vacuolation (spongiform change) and prion protein deposition in 11 patients with sporadic Creutzfeldt-Jakob disease.
    Armstrong RA; Cairns NJ; Lantos PL
    Acta Neuropathol; 2001 Dec; 102(6):591-6. PubMed ID: 11761719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parvalbumin and calbindin D-28K in the human entorhinal cortex. An immunohistochemical study.
    Tuñón T; Insausti R; Ferrer I; Sobreviela T; Soriano E
    Brain Res; 1992 Aug; 589(1):24-32. PubMed ID: 1422819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of perikaryal parvalbumin immunoreactivity from surviving GABAergic neurons in the CA1 field of epileptic gerbils.
    Scotti AL; Bollag O; Kalt G; Nitsch C
    Hippocampus; 1997; 7(5):524-35. PubMed ID: 9347349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parvalbumin-immunoreactive cortical neurons in Creutzfeldt-Jakob disease.
    Ferrer I; Casas R; Rivera R
    Ann Neurol; 1993 Dec; 34(6):864-6. PubMed ID: 8250537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GluR2/3, NMDAepsilon1 and GABAA receptors in Creutzfeldt-Jakob disease.
    Ferrer I; Puig B
    Acta Neuropathol; 2003 Oct; 106(4):311-8. PubMed ID: 12835949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term structural changes in the rat hippocampal formation following cerebral ischemia.
    Mudrick LA; Baimbridge KG
    Brain Res; 1989 Jul; 493(1):179-84. PubMed ID: 2776006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nigrostriatal pathway in Creutzfeldt-Jakob disease.
    Vital A; Fernagut PO; Canron MH; Joux J; Bezard E; Martin-Negrier ML; Vital C; Tison F
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):809-15. PubMed ID: 19535991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal phosphorylated RNA-dependent protein kinase in Creutzfeldt-Jakob disease.
    Paquet C; Bose A; Polivka M; Peoc'h K; Brouland JP; Keohane C; Hugon J; Gray F
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):190-8. PubMed ID: 19151623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of neuronal migration disorders in neocortical structures: loss or preservation of inhibitory interneurons?
    Schwarz P; Stichel CC; Luhmann HJ
    Epilepsia; 2000 Jul; 41(7):781-7. PubMed ID: 10897147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial respiratory chain deficiency correlates with the severity of neuropathology in sporadic Creutzfeldt-Jakob disease.
    Flønes IH; Ricken G; Klotz S; Lang A; Ströbel T; Dölle C; Kovacs GG; Tzoulis C
    Acta Neuropathol Commun; 2020 Apr; 8(1):50. PubMed ID: 32299489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creutzfeldt-Jakob disease with extensive degeneration of white matter.
    Park TS; Kleinman GM; Richardson EP
    Acta Neuropathol; 1980; 52(3):239-42. PubMed ID: 7004049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of parvalbumin-, calretinin-, and calbindin-D28k-immunoreactive neurons and fibers in the human entorhinal cortex.
    Mikkonen M; Soininen H; Pitkänen A
    J Comp Neurol; 1997 Nov; 388(1):64-88. PubMed ID: 9364239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactive microglia in Creutzfeldt-Jakob disease.
    Mühleisen H; Gehrmann J; Meyermann R
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):505-17. PubMed ID: 8745240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathological findings in new variant CJD and experimental transmission of BSE.
    Ironside JW
    FEMS Immunol Med Microbiol; 1998 Jun; 21(2):91-5. PubMed ID: 9684997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An autopsied case of V180I Creutzfeldt-Jakob disease presenting with panencephalopathic-type pathology and a characteristic prion protein type.
    Iwasaki Y; Mori K; Ito M; Nagaoka M; Ieda T; Kitamoto T; Yoshida M; Hashizume Y
    Neuropathology; 2011 Oct; 31(5):540-8. PubMed ID: 21269331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.